Keytruda
Imported from official source
Keytruda Active substance Pembrolizumab Holder MSD Belgium BV/SRL Status Running Indication in combination with paclitaxel with or without bevacizumab, is indicated for the treatment of platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma in adults whose tumours express PD-L1 with a CPS ≥1 and who have received one or two prior treatment regimens. …
This version
- Version
- 1 of 1
- Recorded
- November 17, 2026 09:31
- Change
- Initial
- Content hash
1f605083e6b51c8409d725e09a97ee31- All versions
- Revision history